InvestorsHub Logo
Followers 482
Posts 30219
Boards Moderated 0
Alias Born 06/15/2007

Re: Scott12 post# 25429

Friday, 03/23/2018 1:29:30 PM

Friday, March 23, 2018 1:29:30 PM

Post# of 27676
Sounds like looking for insider information I just do not have. You have the email address to Rich Pharmaceuticals? If not then all you have to do is look or ask and I am sure one can be provided. I have been posting on this board way back after the RS when crickets were chirping.


There are catalysts in the works. You have seen the news yes? What do you think about the following news for example?


Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology, announced today the potential for using its drug RP-323 (TPA) in the treatment of Hodgkin's lymphoma.

Hodgkin's lymphoma is a cancer that is found most frequently in two different age groups: 15 - 35 and over 55. It occurs in both sexes although it is more common in males. Cancer cells invade and destroy the architecture of the lymph nodes and infiltrate the liver, the spleen or other parts of the body. In the U.S., more than 100,000 people suffer from Hodgkin's lymphoma.

"A phase I clinical trial conducted at The Cancer Institute of New Jersey have shown that RP-323 treatment reduced a palpable tumor mass after three weeks in a patient with Hodgkin's lymphoma. We look forward to being able to commence clinical trials in the future to prove that using RP-323 alone or in combination with other anticancer agents will have significant therapeutic activity against Hodgkin's lymphoma," said Rich Pharmaceuticals CEO, Ben Chang. "Clinical studies in China have also demonstrated that IV administration of RP-323 resulted in remission in some patients with myelocytic leukemia."




We are not taking about something imagined here. We are not taking about "Smoke And Mirrors" as one might on most of the OTC boards when no catalysts but only speculation is being discussed.


So what do you think about such news? You think this could be beneficial to ones who have such a debilitating disease?



To your specific question. We all know that this can only be answered by the Company.





$RCHA



PEPSI

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.